Correlation Between Mesa Laboratories and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mesa Laboratories and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mesa Laboratories and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mesa Laboratories and Structure Therapeutics American, you can compare the effects of market volatilities on Mesa Laboratories and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mesa Laboratories with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mesa Laboratories and Structure Therapeutics.
Diversification Opportunities for Mesa Laboratories and Structure Therapeutics
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Mesa and Structure is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Mesa Laboratories and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Mesa Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mesa Laboratories are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Mesa Laboratories i.e., Mesa Laboratories and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Mesa Laboratories and Structure Therapeutics
Given the investment horizon of 90 days Mesa Laboratories is expected to generate 0.66 times more return on investment than Structure Therapeutics. However, Mesa Laboratories is 1.51 times less risky than Structure Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.01 per unit of risk. If you would invest 9,484 in Mesa Laboratories on November 9, 2024 and sell it today you would earn a total of 4,689 from holding Mesa Laboratories or generate 49.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mesa Laboratories vs. Structure Therapeutics America
Performance |
| Timeline |
| Mesa Laboratories |
| Structure Therapeutics |
Mesa Laboratories and Structure Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mesa Laboratories and Structure Therapeutics
The main advantage of trading using opposite Mesa Laboratories and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mesa Laboratories position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.| Mesa Laboratories vs. Novanta | Mesa Laboratories vs. Itron Inc | Mesa Laboratories vs. Fortive Corp | Mesa Laboratories vs. Vishay Precision Group |
| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |